Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brinch, Shoshy Alam"'
Autor:
Mygland, Line, Brinch, Shoshy Alam, Strand, Martin Frank, Olsen, Petter Angell, Aizenshtadt, Aleksandra, Lund, Kaja, Solberg, Nina Therese, Lycke, Max, Thorvaldsen, Tor Espen, Espada, Sandra, Misaghian, Dorna, Page, Christian M., Agafonov, Oleg, Nygård, Ståle, Chi, Nai-Wen, Lin, Eva, Tan, Jenille, Yu, Yihong, Costa, Mike, Krauss, Stefan, Waaler, Jo
Publikováno v:
In iScience 23 July 2021 24(7)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Waaler, Jo, Mygland, Line, Tveita, Anders Aune, Strand, Martin Frank, Solberg, Nina, Olsen, Petter Angell, Aizenshtadt, Aleksandra, Fauskanger, Marte, Lund, Kaja, Mahmuda, Shoshy (Brinch, Shoshy Alam), Lycke, Eric Maximilian, Dybing, Elisabeth, Nygaard, Vegard, Bøe, Sigurd, Heintz, Karen Marie, Hovig, Eivind, Hammarström, Clara Louise, Corthay, Alexandre, Krauss, Stefan
Externí odkaz:
https://hdl.handle.net/11250/2736687
Autor:
Waaler, Jo, Leenders, Ruben G G, Sowa, Sven T., Brinch, Shoshy Alam, Lycke, Eric Maximilian, Nieczypor, Piotr, Aertssen, Sjoerd, Murthy, Sudarshan, Galera-Prat, Albert, Damen, Eddy, Wegert, Anita, Nazaré, Marc, Lehtiö, Lari, Krauss, Stefan
Publikováno v:
Waaler, Jo Leenders, Ruben G G Sowa, Sven T. Brinch, Shoshy Alam Lycke, Eric Maximilian Nieczypor, Piotr Aertssen, Sjoerd Murthy, Sudarshan Galera-Prat, Albert Damen, Eddy Wegert, Anita Nazaré, Marc Lehtiö, Lari Krauss, Stefan . Preclinical lead optimization of a 1,2,4-triazole based tankyrase inhibitor. Jo
Jo
Jo
Externí odkaz:
http://hdl.handle.net/10852/84499
https://www.duo.uio.no/bitstream/handle/10852/84499/4/acs.jmedchem.0c00208.pdf
https://www.duo.uio.no/bitstream/handle/10852/84499/4/acs.jmedchem.0c00208.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Waaler J; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway. jo.waaler@rr-research.no.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway. jo.waaler@rr-research.no., Mygland L; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Tveita A; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway., Strand MF; School of Health Sciences, Kristiania University College, P.O. Box 1190, Sentrum, 0107, Oslo, Norway., Solberg NT; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Olsen PA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Aizenshtadt A; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Fauskanger M; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway., Lund K; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Brinch SA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Lycke M; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Dybing E; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Nygaard V; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, 0424, Oslo, Norway., Bøe SL; Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379, Oslo, Norway., Heintz KM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, 0424, Oslo, Norway., Hovig E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, 0424, Oslo, Norway.; Center of Bioinformatics, Department of Informatics, University of Oslo, P.O. Box 1080, Blindern, 0316, Oslo, Norway., Hammarström C; Department of Pathology, Oslo University Hospital, Rikshospitalet, P.O. box 4950, Nydalen, 0424, Oslo, Norway., Corthay A; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Rikshospitalet, P.O. box 4950, Nydalen, 0424, Oslo, Norway., Krauss S; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway.
Publikováno v:
Communications biology [Commun Biol] 2020 Apr 24; Vol. 3 (1), pp. 196. Date of Electronic Publication: 2020 Apr 24.